News Release 25-Sep-2024 Peer-Reviewed PublicationCompuscript Ltd This new article publication from Acta Pharmaceutica Sinica B, discusses the use of in situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases. Tumor vaccine, a promising modality of tumor immunotherapy, needs to go through the process of tumor antigen generation...